Taiwan Food and Drug Administration

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...

South Korea has proposed forming a consortium with Japan, Taiwan and Vietnam to jointly assess the feasibility of investing in the $45 billion Alask...

South Korea plans to issue up to $1.2 billion in foreign exchange stabilization bonds as early as June, in what would mark the new administration&rs...

South Korea’s processed food exports to India have surged to a record 6 trillion won ($4.1 billion), marking a significant milestone in the gr...

South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...

Chey Tae-won, chairman of SK Group, the parent of SK Hynix Inc., is visiting Taiwan amid the threat of escalating US tariff threats, suggesting the ...

Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...

Orchestra Private Equity has begun the process of divesting the South Korean operations of fast-food chain KFC, which has seen earnings growth since...

South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...

South Korea’s top and third-ranked food delivery apps, Baedal Minjok (Baemin) and Yogiyo, saw their biggest-ever monthly drops in transaction ...

South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determine the best dose for a cancer drug combination in clinical tria...

Chong Kun Dang Pharmaceutical Corp. is discussing building a research center and a plant in Siheung, about 30 kilometers southwest of Seoul, with th...

Coupang Inc., South Korea’s answer to global e-commerce giant Amazon.com, ended last year with profit for the second straight year thanks to t...

Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...

Coupang Eats, a food delivery app operated by South Korea's No. 1 e-commerce platform Coupang Inc., launched its first overseas service in Japan.Acc...

SAN FRANCISCO -- Lotte Biologics Co., the drug consignment development and production unit of South Korean conglomerate Lotte Group, will seek to wi...

SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...

South Korea’s SK Biopharmaceuticals Co. has signed a deal with Brazil’s Eurofarma Laboratórios S.A. to establish a joint venture ...

South Korean food, beauty and fashion companies, which have enjoyed robust demand for their products in overseas markets this year, will grow bolder...

Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...

South Korea's office cafeteria companies, including Hyundai Green Food Co., Ourhome, and Samsung Welstory plan to expand overseas markets with the p...

South Korea and the Philippines free trade agreement (FTA) is expected to increase exports to the Philippines, especially cars and parts, which will...

Hyundai Rotem Co., a South Korean rolling stock and defense equipment maker, said on Friday it held a ceremony to mark the arrival of the first ba...

South Korean leading food maker Daesang Corp., the operator of kimchi brand Jongga, said on Thursday it launched San Ho Won with three-Michelin-star...

South Korea's Samyang Foods Co. said on Monday it will build its first overseas plant in China. The company plans to invest 64.7 billion won ($...

South Korea's Boryung Corp. said on Thursday it signed a contract with Lotus Pharmaceutical, a Taiwanese oncology firm, for contract development and...

South Korea's Samyang Foods Co. said on Wednesday it launched the new export-only ramyun brand Mep in Thailand. Mep is the second brand for the...

South Korea's SK Biopharmaceuticals Co. said on Tuesday it submitted the new drug application (NDA) for its flagship epilepsy drug Cenobamate to Chi...

Celltrion Inc.'s Remsima, the world’s first biosimilar monoclonal antibody, is on track to exceed 1 trillion won ($713 million) in sales this ...

South Korea’s Hanmi Pharmaceutical Co. announced on Thursday the launch of its anti-obesity drug candidate efpeglenatide has been rescheduled ...